Results 171 to 180 of about 1,317,105 (347)

The Role of Brain-Derived Neurotrophic Factor Signaling in Central Nervous System Disease Pathogenesis. [PDF]

Front Hum Neurosci, 2022
Dou SH, Cui Y, Huang SM, Zhang B.
europepmc   +1 more source

Impact of Travel Distance on Radiation Treatment Modality for Central Nervous System Disease

, 2019
Shearwood McClelland, Timur Mitin, Jerry J. Jaboin, Jeremy Ciporen   +3 more
openalex   +1 more source

Functional Connectivity Linked to Cognitive Recovery After Minor Stroke

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Patients with minor stroke exhibit slowed processing speed and generalized alterations in functional connectivity involving frontoparietal cortex (FPC). The pattern of connectivity evolves over time. In this study, we examine the relationship of functional connectivity patterns to cognitive performance, to determine ...
Vrishab Commuri, Isabella Dallasta, Ciaran Stone, Sophia Girgenti, Neda Gould, Rafael H. Llinas, Jonathan Z. Simon, Elisabeth Breese Marsh   +7 more
wiley   +1 more source

B cells in central nervous system disease: diversity, locations and pathophysiology. [PDF]

Nat Rev Immunol, 2022
Jain RW, Yong VW.
europepmc   +1 more source

GCT-25. THE IMPACT OF RESIDUAL DISEASE ON THE OUTCOMES OF CENTRAL NERVOUS SYSTEM GERMINOMAS – A MULTICENTER INSTITUTION EXPERIENCE [PDF]

Jimin Shin, Anne Cochrane, Andrea Ogle, Ashley Meyer, Nicole M Brossier, Margaret Shatara, Andrew Cluster, Truman Knowles, Sabine Mueller, Małgorzata Czogała, Evan Cantor, Mohamed S Abdelbaki   +11 more
openalex   +1 more source

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease [PDF]

, 2008
Leah R. Hanson, William H. Frey
openalex   +1 more source

Discovery and Targeted Proteomic Studies Reveal Striatal Markers Validated for Huntington's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Clinical trials for Huntington's disease (HD) enrolling persons before clinical motor diagnosis (CMD) lack validated biomarkers. This study aimed to conduct an unbiased discovery analysis and a targeted examination of proteomic biomarkers scrutinized by clinical validation. Methods Cerebrospinal fluid was obtained from PREDICT‐HD and
Daniel Chelsky, Cara Joyce, H. Jeremy Bockholt, Paul A. Rudnick, William H. Adams, Fiona McAllister, Justin W. Smock, Michael A. Newton, Jane S. Paulsen   +8 more
wiley   +1 more source

Effects of Cognitive Reserve on Cognition in Individuals With Central Nervous System Disease. [PDF]

Cogn Behav Neurol, 2021
Jammula VR, Leeper H, Gilbert MR, Cooper D, Armstrong TS.   +4 more
europepmc   +1 more source

Complete remission of central nervous system manifestations of IgG4-related disease with rituximab – a case report [PDF]

, 2023
Aleksi J. Sihvonen, Sini M. Laakso, Olli Tynninen, Heikki Saaren‐Seppälä, Mervi Löfberg   +4 more
openalex   +1 more source

Effectiveness and Safety of Nusinersen and Risdiplam in Spinal Muscular Atrophy: A Systematic Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Spinal Muscular Atrophy (SMA) is a rare genetic disorder marked by progressive muscle weakness and mobility loss. It has a profound physical, emotional and social impact on patients and caregivers, requiring comprehensive medical and supportive care.
Amin Mehrabian, Peter Auguste, Amy Grove, Anna Brown, Janette Parr, Mubarak Patel, Furqan Butt, Jeremiah Donoghue, Mehdi Yousefi, Jo Parsons   +9 more
wiley   +1 more source